IL-1β-Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted Proteases Is Mediated by Human β-Defensin 2

详细信息    查看全文

• 作者：Bingjie Wang¹ ; ⁴ ; Brian J. McHugh¹ ; ⁴ ; Ayub Qureshi¹ ; ⁴ ; Dominic J. Campopiano² ; David J. Clarke² ; J. Ross Fitzgerald³ ; Julia R. Dorin¹ ; Richard Weller¹ ; Donald J. Davidson¹ ; ^{donald.davidson@ed.ac.uk}
• 关键词：AD ; atopic dermatitis ; hBD ; human β-defensin ; HDP ; host defense peptide ; HPEK ; human primary epidermal keratinocyte ; LPS ; lipopolysaccharide ; LTA ; lipoteichoic acid ; OE ; overexpressing ; shRNA ; small hairpin RNA ; Ssp ; staphylococcus aureus serine protease ; TJ ; tight junction ; VO ; vector only
• 刊名：Journal of Investigative Dermatology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：137
• 期：1
• 页码：95-105
• 全文大小：3073 K
• 卷排序：137

文摘

Atopic dermatitis (AD) is a common chronic inflammatory skin disease that results in significant morbidity. A hallmark of AD is disruption of the critical barrier function of upper epidermal layers, causatively linked to environmental stimuli, genetics, and infection, and a critical current target for the development of new therapeutic and prophylactic interventions. Staphylococcus aureus is an AD-associated pathogen producing virulence factors that induce skin barrier disruption in vivo and contribute to AD pathogenesis. We show, using immortalized and primary keratinocytes, that S. aureus protease SspA/V8 is the dominant secreted factor (in laboratory and AD clinical strains of S. aureus) inducing barrier integrity impairment and tight junction damage. V8-induced integrity damage was inhibited by an IL-1β–mediated mechanism, independent of effects on claudin-1. Induction of keratinocyte expression of the antimicrobial/host defense peptide human β-defensin 2 (hBD2) was found to be the mechanism underpinning this protective effect. Endogenous hBD2 expression was required and sufficient for protection against V8 protease-mediated integrity damage, and exogenous application of hBD2 was protective. This modulatory property of hBD2, unrelated to antibacterial effects, gives new significance to the defective induction of hBD2 in the barrier-defective skin lesions of AD and indicates therapeutic potential.